FI58943C - Foerfarande foer samtidig eller enskild bestaemning av laktatdehydrogenasernas isoenzymer - Google Patents
Foerfarande foer samtidig eller enskild bestaemning av laktatdehydrogenasernas isoenzymer Download PDFInfo
- Publication number
- FI58943C FI58943C FI752550A FI752550A FI58943C FI 58943 C FI58943 C FI 58943C FI 752550 A FI752550 A FI 752550A FI 752550 A FI752550 A FI 752550A FI 58943 C FI58943 C FI 58943C
- Authority
- FI
- Finland
- Prior art keywords
- lactate
- buffer
- ldh
- tampon
- nad
- Prior art date
Links
- 108010044467 Isoenzymes Proteins 0.000 claims description 27
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 24
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000000872 buffer Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 13
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 13
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 229950006238 nadide Drugs 0.000 claims description 11
- 238000003556 assay Methods 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 238000010186 staining Methods 0.000 claims description 9
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 8
- 108010088350 Lactate Dehydrogenase 5 Proteins 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 108010088351 lactate dehydrogenase 4 Proteins 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 230000028327 secretion Effects 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 claims 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 claims 2
- 108010020056 Hydrogenase Proteins 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 210000003756 cervix mucus Anatomy 0.000 claims 1
- 108010088074 lactate dehydrogenase 3 Proteins 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 33
- 239000012530 fluid Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 239000011888 foil Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 6
- 210000001215 vagina Anatomy 0.000 description 6
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000005259 measurement Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 201000009030 Carcinoma Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000012464 large buffer Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- CYTCTRAEJYIZRX-UHFFFAOYSA-N (9a-hydroxy-3,5a-dimethyl-9-methylidene-2-oxo-3,3a,4,5,6,7,8,9b-octahydrobenzo[g][1]benzofuran-6-yl) acetate Chemical compound C1CC2(C)C(OC(C)=O)CCC(=C)C2(O)C2C1C(C)C(=O)O2 CYTCTRAEJYIZRX-UHFFFAOYSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 1
- 208000009458 Carcinoma in Situ Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 231100000416 LDH assay Toxicity 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000011340 continuous therapy Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000004933 in situ carcinoma Diseases 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 108010087599 lactate dehydrogenase 1 Proteins 0.000 description 1
- 238000002843 lactate dehydrogenase assay Methods 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 101150095787 ldh2 gene Proteins 0.000 description 1
- 101150100271 ldhb gene Proteins 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S604/00—Surgery
- Y10S604/904—Tampons
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2443741 | 1974-09-12 | ||
| DE19742443741 DE2443741C3 (de) | 1974-09-12 | Verfahren zur gemeinsamen Bestimmung der Isoenzyme 4 und 5 der LDH |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI752550A FI752550A (ja) | 1976-03-13 |
| FI58943B FI58943B (fi) | 1981-01-30 |
| FI58943C true FI58943C (fi) | 1981-05-11 |
Family
ID=5925603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI752550A FI58943C (fi) | 1974-09-12 | 1975-09-11 | Foerfarande foer samtidig eller enskild bestaemning av laktatdehydrogenasernas isoenzymer |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US4003795A (ja) |
| JP (2) | JPS5512239B2 (ja) |
| AR (1) | AR211523A1 (ja) |
| AT (1) | AT351173B (ja) |
| AU (1) | AU503460B2 (ja) |
| BE (1) | BE833348A (ja) |
| BR (1) | BR7505850A (ja) |
| CA (1) | CA1076010A (ja) |
| CH (1) | CH631209A5 (ja) |
| CS (1) | CS251752B2 (ja) |
| DD (1) | DD120296A1 (ja) |
| DK (1) | DK144659C (ja) |
| ES (1) | ES440870A1 (ja) |
| FI (1) | FI58943C (ja) |
| FR (1) | FR2284882A1 (ja) |
| GB (1) | GB1527243A (ja) |
| HK (1) | HK79879A (ja) |
| HU (1) | HU171962B (ja) |
| IE (1) | IE41901B1 (ja) |
| IL (1) | IL48071A (ja) |
| IN (1) | IN142896B (ja) |
| IT (1) | IT1155451B (ja) |
| NL (1) | NL178086C (ja) |
| NO (1) | NO144929C (ja) |
| PL (1) | PL98619B1 (ja) |
| RO (1) | RO68447A (ja) |
| SE (1) | SE417109B (ja) |
| SU (2) | SU663329A3 (ja) |
| TR (1) | TR19139A (ja) |
| YU (1) | YU218175A (ja) |
| ZA (1) | ZA755704B (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311791A (en) * | 1978-06-05 | 1982-01-19 | Bernstein Larry H | Automated kinetic determination of lactate dehydrogenase isoenzymes in serum |
| US4309184A (en) * | 1980-05-08 | 1982-01-05 | Majid Ali | Method of determining food or chemical allergy and intolerance |
| US4543327A (en) * | 1980-06-10 | 1985-09-24 | Bernstein Larry H | Malate dehydrogenase method |
| DE3231288C2 (de) * | 1982-08-23 | 1984-06-28 | MEDI-PHARMA Vertriebsgesellschaft mbH, 5000 Köln | Diagnostische Vorrichtung und ihre Verwendung |
| DE3231287C2 (de) * | 1982-08-23 | 1984-09-06 | MEDI-PHARMA Vertriebsgesellschaft mbH, 5000 Köln | Verfahren zum Herstellen einer diagnostischen Vorrichtung |
| GB2147415B (en) * | 1983-08-05 | 1987-02-11 | Powell & Scholefield Limited | Device and method for antibiotic sensitivity testing |
| DK427784A (da) * | 1984-09-06 | 1986-03-07 | Forenede Bryggerier As | Fremgangsmaade og apparat til bestemmelse af vitalitet i froe |
| US4849347A (en) * | 1984-11-29 | 1989-07-18 | Hoffmann-La Roche Inc. | Colorimetric biological assay |
| US5141853A (en) * | 1988-07-22 | 1992-08-25 | Abbott Laboratories | Determination of ammonia levels in a sample |
| ES2070211T3 (es) * | 1989-06-09 | 1995-06-01 | Abbott Lab | Metodo para el ensayo de isoenzimas. |
| US5468236A (en) * | 1993-06-09 | 1995-11-21 | Kimberly-Clark Corporation | Disposable absorbent product incorporating chemically reactive substance |
| US7947467B2 (en) * | 2001-07-19 | 2011-05-24 | Common Sense Ltd. | Methods for monitoring pathological conditions in a female subject |
| US20070134740A1 (en) * | 2005-12-12 | 2007-06-14 | David Brusilovsky | Compositions and articles for detection of analytes exceeding a pre-set threshold |
| US7083569B2 (en) * | 2001-08-03 | 2006-08-01 | Zassi Medical Evolutions, Inc. | Ostomy cartridge |
| US20070031914A1 (en) * | 2005-08-05 | 2007-02-08 | Wei Zhu | Devices for analyte assays and methods of use |
| US8053625B2 (en) * | 2006-12-14 | 2011-11-08 | Kimberly-Clark Worldwide, Inc. | Absorbent articles including a body fluid signaling device |
| CN105277656B (zh) | 2014-07-01 | 2018-12-25 | 科蒙森斯公司 | 用于鉴定羊水的诊断组合物 |
| CN113329697A (zh) * | 2019-01-23 | 2021-08-31 | 吉娜-生命诊断有限公司 | 癌症诊断和监测设备、其系统和方法 |
| JPWO2020170977A1 (ja) | 2019-02-19 | 2020-08-27 | ||
| US20230054322A1 (en) * | 2021-08-23 | 2023-02-23 | Leslie P. Taylor | Urine indication pad with inbuilt diagnostics for training and indication of potential disease |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2905169A (en) * | 1955-03-10 | 1959-09-22 | Herbert E Nieburgs | Device for cancer detection |
| US2999052A (en) | 1959-03-16 | 1961-09-05 | Miles Lab | Composition for colorimetric test for serum enzymes |
| US3326777A (en) * | 1964-12-10 | 1967-06-20 | Warner Lambert Pharmaceutical | Process for differentiating the isoenzymes of lactic dehydrogenase |
| US3388044A (en) * | 1965-12-07 | 1968-06-11 | Warner Lambert Pharmaceutical | Process for differentiating the isoenzymes of lactic dehydrogenase |
| DE1959410C3 (de) * | 1969-11-26 | 1974-02-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Indikator zur Bestimmung der reduzierten Pyridincöenzyme |
| US3663374A (en) * | 1970-08-14 | 1972-05-16 | Geomet | Method and apparatus for quantitating enzyme activity |
| DE2061984C3 (de) | 1970-12-16 | 1974-04-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Reagens zur Bestimmung der Lactat-Dehydrogenase im Farbtest |
| US3862010A (en) * | 1972-06-09 | 1975-01-21 | Technicon Instr | Method of heat fractionating ldh into isoenzyme components |
| US3867258A (en) * | 1973-11-08 | 1975-02-18 | American Cyanamid Co | Lactate dehydrogenase test material |
| US4046634A (en) * | 1974-05-28 | 1977-09-06 | Mercer Donald W | Assay of isoenzymes by ion exchange chromatography |
| US4080263A (en) * | 1976-08-11 | 1978-03-21 | Boehringer Mannheim Gmbh | Process and reagent for the rapid quantitative determination of lactate or alanine |
-
1975
- 1975-08-27 YU YU02181/75A patent/YU218175A/xx unknown
- 1975-08-29 AT AT667075A patent/AT351173B/de not_active IP Right Cessation
- 1975-09-01 NL NLAANVRAGE7510277,A patent/NL178086C/xx not_active IP Right Cessation
- 1975-09-03 GB GB36351/75A patent/GB1527243A/en not_active Expired
- 1975-09-05 ZA ZA00755704A patent/ZA755704B/xx unknown
- 1975-09-09 IT IT69244/75A patent/IT1155451B/it active
- 1975-09-10 DD DD188274A patent/DD120296A1/xx unknown
- 1975-09-10 IL IL48071A patent/IL48071A/xx unknown
- 1975-09-10 RO RO7583353A patent/RO68447A/ro unknown
- 1975-09-11 FI FI752550A patent/FI58943C/fi not_active IP Right Cessation
- 1975-09-11 AU AU84720/75A patent/AU503460B2/en not_active Expired
- 1975-09-11 CA CA235,284A patent/CA1076010A/en not_active Expired
- 1975-09-11 CH CH1178775A patent/CH631209A5/de not_active IP Right Cessation
- 1975-09-11 DK DK406475A patent/DK144659C/da not_active IP Right Cessation
- 1975-09-11 BR BR7505850*A patent/BR7505850A/pt unknown
- 1975-09-11 SE SE7510130A patent/SE417109B/xx not_active IP Right Cessation
- 1975-09-11 ES ES440870A patent/ES440870A1/es not_active Expired
- 1975-09-12 FR FR7528099A patent/FR2284882A1/fr active Granted
- 1975-09-12 CS CS756214A patent/CS251752B2/cs unknown
- 1975-09-12 JP JP11079975A patent/JPS5512239B2/ja not_active Expired
- 1975-09-12 US US05/612,633 patent/US4003795A/en not_active Expired - Lifetime
- 1975-09-12 NO NO753119A patent/NO144929C/no unknown
- 1975-09-12 TR TR19139A patent/TR19139A/xx unknown
- 1975-09-12 BE BE159982A patent/BE833348A/xx not_active IP Right Cessation
- 1975-09-12 IE IE2000/75A patent/IE41901B1/en unknown
- 1975-09-12 AR AR260373A patent/AR211523A1/es active
- 1975-09-12 PL PL1975183289A patent/PL98619B1/pl unknown
- 1975-09-12 SU SU752171403A patent/SU663329A3/ru active
- 1975-09-12 HU HU75SCHA170A patent/HU171962B/hu unknown
- 1975-10-09 IN IN1960/CAL/1975A patent/IN142896B/en unknown
-
1976
- 1976-09-09 SU SU762405873A patent/SU657732A3/ru active
-
1978
- 1978-07-10 US US05/923,641 patent/US4266022A/en not_active Expired - Lifetime
-
1979
- 1979-11-15 HK HK798/79A patent/HK79879A/xx unknown
- 1979-11-22 JP JP54150822A patent/JPS5850720B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI58943C (fi) | Foerfarande foer samtidig eller enskild bestaemning av laktatdehydrogenasernas isoenzymer | |
| FI76379C (fi) | Medel och foerfarande foer snabb diagnos av tandkaries medelst ett icke-vaotfoerfarande. | |
| US8906693B2 (en) | Materials and methods for measuring nitric oxide levels in biological fluids | |
| KR101821002B1 (ko) | 양호한 건강의 바이오마커를 검출하기 위한 질 표시기 | |
| WO2016058511A1 (zh) | 一种血清岩藻糖苷酶检测试剂盒 | |
| JPS60230065A (ja) | 血糖値全日プロフイル作成用テスト・ストリツプおよびその製造方法 | |
| Peterson et al. | Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects | |
| JPS5950362A (ja) | 女性胸部の癌の診断及び検出方法 | |
| Elhilali et al. | Lactate dehydrogenase isoenzymes in hyperplasia and carcinoma of the prostate: a clinical study | |
| JPS5955199A (ja) | 診断具 | |
| Liu et al. | A self-immobilizing NIR probe for non-invasive imaging of senescence | |
| EP0028644A1 (en) | Impending ovulation test | |
| CN112485246B (zh) | 一种单项上皮组织肿瘤细胞渗液游离血红素显色液 | |
| US4157279A (en) | Process for the determination of at least one of the isoenzymes of lactatedehydrogenase | |
| Dernroth et al. | Pheomelanin-related benzothiazole isomers in the urine of patients with diffuse melanosis of melanoma | |
| CN110343099B (zh) | 一种基于双光子荧光团的有机化合物及应用 | |
| CN111575341B (zh) | 一种利用巯丙基琼脂糖球负载尿酸酶和过氧化氢酶检测尿酸的方法 | |
| WO1980002800A1 (en) | Specific impending ovulation indicator | |
| Toates | The forensic identification of semen by isoelectric focusing of seminal acid phosphatase | |
| CN111575340B (zh) | 一种利用巯丙基琼脂糖球负载葡萄糖氧化酶和过氧化氢酶检测葡萄糖的方法 | |
| CN117804876B (zh) | 一种叶酸受体介导上皮组织细胞染色液及其制备方法 | |
| RU2111495C1 (ru) | Способ диагностики злокачественной опухоли | |
| DE2443741C3 (de) | Verfahren zur gemeinsamen Bestimmung der Isoenzyme 4 und 5 der LDH | |
| CN105132415A (zh) | 锰超氧化物歧化酶sod2的体外分子检测方法及引物 | |
| RU2194278C2 (ru) | Тест-полоска для определения глюкозы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: ESAI CO. LTD. |